Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.0 - $1.39 $133,712 - $185,859
133,712 Added 144.69%
226,127 $248,000
Q3 2023

Nov 14, 2023

BUY
$1.22 - $4.83 $16,222 - $64,224
13,297 Added 16.81%
92,415 $113,000
Q2 2023

Aug 11, 2023

BUY
$2.95 - $4.44 $78,440 - $118,059
26,590 Added 50.62%
79,118 $309,000
Q1 2023

May 16, 2023

SELL
$2.94 - $4.18 $251,346 - $357,356
-85,492 Reduced 61.94%
52,528 $172,000
Q4 2022

Feb 14, 2023

SELL
$2.73 - $3.7 $197,963 - $268,301
-72,514 Reduced 34.44%
138,020 $401,000
Q3 2022

Nov 14, 2022

BUY
$0.48 - $3.48 $51,259 - $371,632
106,791 Added 102.94%
210,534 $536,000
Q2 2022

Aug 15, 2022

BUY
$2.22 - $4.54 $188,622 - $385,741
84,965 Added 452.47%
103,743 $230,000
Q1 2022

May 16, 2022

SELL
$3.58 - $4.98 $1.18 Million - $1.65 Million
-330,333 Reduced 94.62%
18,778 $79,000
Q2 2021

Aug 11, 2021

BUY
$6.69 - $9.0 $1.52 Million - $2.04 Million
226,736 Added 185.28%
349,111 $2.61 Million
Q1 2021

May 17, 2021

SELL
$8.26 - $11.4 $539,510 - $744,602
-65,316 Reduced 34.8%
122,375 $1.01 Million
Q4 2020

Feb 16, 2021

SELL
$8.21 - $18.59 $2.77 Million - $6.28 Million
-337,560 Reduced 64.27%
187,691 $1.59 Million
Q3 2020

Nov 16, 2020

BUY
$11.33 - $19.81 $4.15 Million - $7.26 Million
366,537 Added 230.94%
525,251 $9.76 Million
Q2 2020

Aug 14, 2020

BUY
$4.2 - $15.45 $568,948 - $2.09 Million
135,464 Added 582.64%
158,714 $1.81 Million
Q1 2020

May 15, 2020

SELL
$3.38 - $10.63 $142,585 - $448,426
-42,185 Reduced 64.47%
23,250 $102,000
Q4 2019

Feb 14, 2020

SELL
$5.74 - $7.42 $78,477 - $101,446
-13,672 Reduced 17.28%
65,435 $482,000
Q3 2019

Nov 14, 2019

BUY
$4.68 - $7.42 $318,609 - $505,146
68,079 Added 617.33%
79,107 $548,000
Q2 2019

Aug 14, 2019

SELL
$4.67 - $5.88 $24,255 - $30,540
-5,194 Reduced 32.02%
11,028 $59,000
Q1 2019

May 15, 2019

BUY
$4.19 - $5.25 $67,970 - $85,165
16,222 New
16,222 $85,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $2.51B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.